GLP-1: Glucagon-like peptide-1 ... Published and preliminary data have shown once-weekly exenatide to result in greater A1c reduction than exenatide twice daily; and as a second- or third-line ...
GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...
The once- and twice-daily GLP-1 RAs are now well established for ... has been shown in most studies to result in a greater reduction of A1c and FPG. While it has not been compared head-to-head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback